Cleared Abbreviated

AeroEclipse* ONE BAN (K200063) - FDA 510(k) Clearance

Class II Anesthesiology device cleared through the Abbreviated 510(k) pathway - typically does not require clinical trials.

K200063 · Trudell Medical International · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2020
Decision
186d
Days
Class 2
Risk

K200063 is an FDA 510(k) clearance for the AeroEclipse* ONE BAN. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Trudell Medical International (London, CA). The FDA issued a Cleared decision on July 17, 2020 after a review of 186 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Trudell Medical International devices

Submission Details

510(k) Number K200063 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 13, 2020
Decision Date July 17, 2020
Days to Decision 186 days
Submission Type Abbreviated
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
46d slower than avg
Panel avg: 140d · This submission: 186d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 75
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K200063.
Corrugated tube with mouthpiece accessory
K203400 · Trudell Medical International · Jun 2021
AireHealth NebulizerTM
K201167 · Airehealth, Inc. · Dec 2020
Portable Mesh Nebulizer
K182906 · Feellife Health, Inc. · Sep 2020
GUS831 Compressor Nebulizer
K192633 · Globalcare Medical Technology Co., Ltd. · May 2020
Propeller Sensor for Symbicort
K192724 · Reciprocal Labs Corporation · Mar 2020
Proneb Max
K191270 · Pari Respiratory Equipment, Inc. · Jan 2020